Ireland
--:--IST
Recruiting Observational

Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation

NCT04146870 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2018-10-01
Last updated
2026-03-19

Condition(s) studied

NutritionHematopoietic Stem Cell Transplantation

Investigational drug(s) / intervention(s)

not have

not have: not have

Study summary

The main objectives of this study were :(1) to comprehensively and systematically evaluate the nutritional status of patients after hematopoietic stem cell transplantation. (2) to explore the effect of nutritional factors on the prognosis of patients treated by hematopoietic stem cell transplantation.

Eligibility

Sex
ALL
Min age
15 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patients who undergo hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University. * Having a life expectancy of more than 3 months Exclusion Criteria: * Not willing to participate in the investigation * Age less than 15 years old or more than 80 years old

Primary outcome measure(s)

  • Change from Baseline fat free mass at 6 months — 6 months
    Body composition analyzer INBO DY S10 (bioelectrical impedance method) is used to analyze the content of fat free mass( kilograms)
  • Change from Baseline fat mass at 6 months — 6 months
    Body composition analyzer INBODY S10 (bioelectrical impedance method) is used to analyze the content of fat mass( kilograms)
  • Change from Baseline food intake at 6 months — 6 months
    24-hour dietary record and semi-quantitative food frequency questionnaire are used to evaluate the eating condition of patients
  • Change from Baseline albumin level in blood at 6 months — 6 months
    The content of albumin in blood is determined.

Trial sites (1)

FacilityCityRegionStatus
The first affiliated hospital of suzhou university Suzhou Jiangsu Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04146870 on ClinicalTrials.gov ↗ ← All trials in China